Arunaloke Chakrabarti

Dr. Arunaloke Chakrabarti

profesor
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
PKPhilipp Koehler
Philipp Koehler
MBMatteo Bassetti
Matteo Bassetti
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
SCSharon Chen
Sharon Chen
Arnaldo L. ColomboArnaldo L. Colombo
Arnaldo L. Colombo
OCOliver A. Cornely
Oliver A. Cornely

21 March 2019 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
HPHariprasath Prakash
Hariprasath Prakash
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and mortality. A change in the epidemiology of mucormycosis has been observed in recent years with the rise in incidence, new causative agents and susceptible population. The rise has been perceived globally, but it is very high in the Asian continent. Though diabetes mellitus overshadow all other risk factors in Asia, post-tuberculosis and chronic renal failure have emerged as new risk groups. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas, pulmonary mucormycosis in patients with haematological malignancy and transplant recipients. In immunocompetent hosts, cutaneous mucormycosis is commonly seen following trauma. The intriguing clinical entity, isolated renal mucormycosis in immunocompetent patients is only reported from China and India. A new clinical entity, indolent mucormycosis in nasal sinuses, is recently recognized. The causative agents of mucormycosis vary across different geographic locations. Though Rhizopus arrhizus is the most common agent isolated worldwide, Apophysomyces variabilis is predominant in Asia and Lichtheimia species in Europe. The new causative agents, Rhizopus homothallicus, Mucor irregularis, and Thamnostylum lucknowense are reported from Asia. In conclusion, with the change in epidemiology of mucormycosis country-wise studies are warranted to estimate disease burden in different risk groups, analyse the clinical disease pattern and identify the new etiological agents.

19 December 2014 in Medical Mycology
Verified
Journal Article
Open access
PDF file
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
ABAlexandro Bonifaz
Alexandro Bonifaz
MGMaria Clara Gutierrez-Galhardo
Maria Clara Gutierrez-Galhardo
TMTakashi Mochizuki
Takashi Mochizuki
SLShanshan Li
Shanshan Li
Sporotrichosis is an endemic mycosis caused by the dimorphic fungus Sporothrix schenckii sensu lato. It has gained importance in recent years due to its worldwide prevalence, recognition of multiple cryptic species within the originally described species, and its distinctive ecology, distribution, and epidemiology across the globe. In this review, we describe the current knowledge of the taxonomy, ecology, prevalence, molecular epidemiology, and outbreaks due to S. schenckii sensu lato. Despite its omnipresence in the environment, this fungus has remarkably diverse modes of infection and distribution patterns across the world. We have delved into the nuances of how sporotrichosis is intimately linked to different forms of human activities, habitats, lifestyles, and environmental and zoonotic interactions. The purpose of this review is to stimulate discussion about the peculiarities of this unique fungal pathogen and increase the awareness of clinicians and microbiologists, especially in regions of high endemicity, to its emergence and evolving presentations and to kindle further research into understanding the unorthodox mechanisms by which this fungus afflicts different human populations.

1 September 2021 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
APAtul Patel
Atul Patel
RARitesh Agarwal
Ritesh Agarwal
SRShivaprakash M. Rudramurthy
Shivaprakash M. Rudramurthy
MSManoj Shevkani
Manoj Shevkani
IXImmaculata Xess
Immaculata Xess
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
COVID-19–Associated Mucormycosis, India

18 June 2009 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
DDDavid W. Denning
David W. Denning
BFBerrylin J. Ferguson
Berrylin J. Ferguson
JPJens Ponikau
Jens Ponikau
WBWalter Buzina
Walter Buzina
BRBishan D. Radotra
Bishan D. Radotra

16 December 2014 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
ACArunaloke Chakrabarti
Arunaloke Chakrabarti
PSPrashant Sood
Prashant Sood
SRShivaprakash Rudramurthy
Shivaprakash Rudramurthy
SCSharon Chen
Sharon Chen
HKHarsimran Kaur
Harsimran Kaur
DMDeepak Mendiratta
Deepak Mendiratta